1.Lynch, T.J. et al. Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib. (2004) N Engl J Med 350, 2129-39.
2.Haber, D.A. et al. Molecular Targeted Therapy of Lung Cancer: EGFR Mutations and Response to EGFR Inhibitors. (2005) Cold Spring Harb Symp Quant Biol 70, 419-26.